4.4 Article

Copy Number Variation of FCGR3B Is Associated with Susceptibility to Idiopathic Pulmonary Fibrosis

期刊

RESPIRATION
卷 81, 期 2, 页码 142-149

出版社

KARGER
DOI: 10.1159/000321997

关键词

Copy number variation; Fc receptors; Gene dosage; Idiopathic pulmonary fibrosis; Neutrophils

资金

  1. British Heart Foundation [FS/05/119/19568]
  2. MRC [G0901697, G108/460] Funding Source: UKRI
  3. Medical Research Council [G9900991B, G108/460, G0901697] Funding Source: researchfish

向作者/读者索取更多资源

Background: Several genes exhibit copy number variation (CNV), including FCGR3B which encodes the IgG receptor Fc gamma RIIIb. Engagement of Fc gamma receptors by IgG complexes may contribute to the pathogenesis of idiopathic pulmonary fibrosis (IPF). Objectives: To investigate whether FCGR3B CNV is associated with susceptibility to IPF. Methods: In a case-control study we compared FCGR3B copy number in 142 patients with IPF and in 221 controls by real-time quantitative PCR using CD36 as gene copy control. Results: Significantly increased FCGR3B:CD36 ratio was evident in the IPF cohort compared to controls (p = 0.009). Association of FCGR3B copy number with IPF susceptibility was further confirmed by a likelihood ratio statistical approach (p = 0.003). FCGR3B copy number assignment based on FCGR3B:CD36 ratios revealed significant skewing in the distribution of FCGR3B copy number between IPF patients and controls. In the IPF cohort, there was increased frequency of > 2 FCGR3B copies compared to controls (0.30 vs. 0.19; chi(2) = 9.27; d.f. 2; p = 0.0097). The presence of > 2 FCGR3B copies was associated with higher risk of IPF (p = 0.01, OR: 1.914, 95% CI: 1.17-3.12). Conclusions: These findings support an association of FCGR3B copy number with susceptibility to IPF and propose a novel role for Fc gamma receptors in IPF disease pathogenesis. Copyright (C) 2010 S. Karger AG, Basel

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Respiratory System

Target inhibition of galectin-3 by inhaled TD139 in patients with idiopathic pulmonary fibrosis

Nikhil Hirani, Alison C. MacKinnon, Lisa Nicol, Paul Ford, Hans Schambye, Anders Pedersen, Ulf J. Nilsson, Hakon Leffler, Tariq Sethi, Susan Tantawi, Lise Gravelle, Robert J. Slack, Ross Mills, Utsa Karmakar, Duncan Humphries, Fredrik Zetterberg, Lucy Keeling, Lyn Paul, Philip L. Molyneaux, Feng Li, Wendy Funston, Ian A. Forrest, A. John Simpson, Michael A. Gibbons, Toby M. Maher

Summary: The study showed that TD139 was safe and well tolerated in healthy subjects and IPF patients, suppressing Gal-3 expression and reducing plasma biomarkers associated with IPF progression.

EUROPEAN RESPIRATORY JOURNAL (2021)

Article Respiratory System

BTS Clinical Statement on pulmonary sarcoidosis

Muhunthan Thillai, Christopher P. Atkins, Anjali Crawshaw, Simon P. Hart, Ling-Pei Ho, Vasileios Kouranos, Karen Patterson, Nicholas J. Screaton, Joanna Whight, Athol U. Wells

THORAX (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Reproducibility of 19F-MR ventilation imaging in healthy volunteers

Benjamin J. Pippard, Mary A. Neal, Adam M. Maunder, Kieren G. Hollingsworth, Alberto Biancardi, Rod A. Lawson, Holly Fisher, John N. S. Matthews, A. John Simpson, Jim M. Wild, Peter E. Thelwall

Summary: This study aimed to assess the reproducibility of %VV measurements in healthy volunteers using F-19-MRI of inhaled perfluoropropane at two research sites. Results showed high consistency and precision in %VV measurements between observers, with minor discrepancies. This supports the feasibility of conducting larger multicenter clinical studies in the future.

MAGNETIC RESONANCE IN MEDICINE (2021)

Article Biochemistry & Molecular Biology

Single-cell multi-omics analysis of the immune response in COVID-19

Emily Stephenson, Gary Reynolds, Rachel A. Botting, Fernando J. Calero-Nieto, Michael D. Morgan, Zewen Kelvin Tuong, Karsten Bach, Waradon Sungnak, Kaylee B. Worlock, Masahiro Yoshida, Natsuhiko Kumasaka, Katarzyna Kania, Justin Engelbert, Bayan Olabi, Jarmila Stremenova Spegarova, Nicola K. Wilson, Nicole Mende, Laura Jardine, Louis C. S. Gardner, Issac Goh, Dave Horsfall, Jim McGrath, Simone Webb, Michael W. Mather, Rik G. H. Lindeboom, Emma Dann, Ni Huang, Krzysztof Polanski, Elena Prigmore, Florian Gothe, Jonathan Scott, Rebecca P. Payne, Kenneth F. Baker, Aidan T. Hanrath, Ina C. D. Schim van der Loeff, Andrew S. Barr, Amada Sanchez-Gonzalez, Laura Bergamaschi, Federica Mescia, Josephine L. Barnes, Eliz Kilich, Angus de Wilton, Anita Saigal, Aarash Saleh, Sam M. Janes, Claire M. Smith, Nusayhah Gopee, Caroline Wilson, Paul Coupland, Jonathan M. Coxhead, Vladimir Yu Kiselev, Stijn van Dongen, Jaume Bacardit, Hamish W. King, Anthony J. Rostron, A. John Simpson, Sophie Hambleton, Elisa Laurenti, Paul A. Lyons, Kerstin B. Meyer, Marko Z. Nikolic, Christopher J. A. Duncan, Kenneth G. C. Smith, Sarah A. Teichmann, Menna R. Clatworthy, John C. Marioni, Berthold Gottgens, Muzlifah Haniffa

Summary: Transcriptomic and proteomic profiling of blood samples from individuals with COVID-19 reveals immune cell and hematopoietic progenitor cell alterations that are differentially associated with disease severity.

NATURE MEDICINE (2021)

Article Pediatrics

Impact of COVID-19 on carers of children with tracheostomies

Nicola Hall, Nikki Rousseau, David W. Hamilton, A. John Simpson, Steven Powell, Malcolm Brodlie, Jason Powell

Summary: The caregivers of children with tracheostomies faced additional challenges during the COVID-19 pandemic, although this was not always their primary concern. Interviews showed rapid adaptation to the constantly changing pandemic-related requirements, rules, and regulations, as well as varying degrees of stoicism and citizenship.

ARCHIVES OF DISEASE IN CHILDHOOD (2022)

Article Immunology

Hypoxia shapes the immune landscape in lung injury and promotes the persistence of inflammation

Ananda S. Mirchandani, Stephen J. Jenkins, Calum C. Bain, Manuel A. Sanchez-Garcia, Hannah Lawson, Patricia Coelho, Fiona Murphy, David M. Griffith, Ailiang Zhang, Tyler Morrison, Tony Ly, Simone Arienti, Pranvera Sadiku, Emily R. Watts, Rebecca S. Dickinson, Leila Reyes, George Cooper, Sarah Clark, David Lewis, Van Kelly, Christos Spanos, Kathryn M. Musgrave, Liam Delaney, Isla Harper, Jonathan Scott, Nicholas J. Parkinson, Anthony J. Rostron, J. Kenneth Baillie, Sara Clohisey, Clare Pridans, Lara Campana, Philip Starkey Lewis, A. John Simpson, David H. Dockrell, Jurgen Schwarze, Nikhil Hirani, Peter J. Ratcliffe, Christopher W. Pugh, Kamil Kranc, Stuart J. Forbes, Moira K. B. Whyte, Sarah R. Walmsley

Summary: Hypoxemia is common in patients with acute respiratory distress syndrome (ARDS) and mouse models of hypoxic acute lung injury. It leads to monocytopenia and reduced accumulation of monocyte-derived macrophages, exacerbating inflammation in the lung. Intervention to rescue monocytopenia and limit injury is a potential therapeutic strategy for ARDS.

NATURE IMMUNOLOGY (2022)

Article Multidisciplinary Sciences

A human model of bilateral pulmonary vein sampling to assess the effects of one-lung ventilation on neutrophil function

Wendy Funston, Marie-Helene Ruchaud-Sparagano, Jonathan Scott, Jason Powell, Faye A. H. Cooles, Lauren Shelmerdine, Cliona McDowell, Denis O'Leary, Karen L. Booth, Stephen C. Clark, Simon J. Ledingham, Anthony J. Rostron, John H. Dark, A. John Simpson

Summary: This study established a bilateral pulmonary vein sampling model in humans, and found that single-lung ventilation during cardiopulmonary bypass had no significant effects on neutrophil function.

PLOS ONE (2022)

Article Cardiac & Cardiovascular Systems

Investigating the diagnostic utility of high-resolution oesophageal manometry in patients with refractory respiratory symptoms

Dominic L. Sykes, Michael G. Crooks, Simon P. Hart, Warren Jackson, John Gallagher, Alyn H. Morice

Summary: This study investigated patterns of esophageal motility in patients with refractory respiratory symptoms using high-resolution esophageal manometry (HROM). The findings revealed that two-thirds of the patients had esophageal dysmotility, suggesting a potential contribution of motility disorders to the development and progression of respiratory diseases.

RESPIRATORY MEDICINE (2022)

Article Critical Care Medicine

Residual Lung Abnormalities after COVID-19 Hospitalization Interim Analysis of the UKILD Post-COVID-19 Study

Iain Stewart, Joseph Jacob, Peter M. George, Philip L. Molyneaux, Joanna C. Porter, Richard J. Allen, Shahab Aslani, J. Kenneth Baillie, Shaney L. Barratt, Paul Beirne, Stephen M. Bianchi, John F. Blaikley, James D. Chalmers, Rachel C. Chambers, Nazia Chadhuri, Christopher Coleman, Guilhem Collier, Emma K. Denneny, Annemarie Docherty, Omer Elneima, Rachael A. Evans, Laura Fabbri, Michael A. Gibbons, Fergus Gleeson, Bibek Gooptu, Neil J. Greening, Beatriz Guillen Guio, Ian P. Hall, Neil A. Hanley, Victoria Harris, Ewen M. Harrison, Melissa Heightman, Toby E. Hillman, Alex Horsley, Linzy Houchen-Wolloff, Ian Jarrold, Simon R. Johnson, Mark G. Jones, Fasihul Khan, Rod Lawson, Olivia Leavy, Nazir Lone, Michael Marks, Hamish McAuley, Puja Mehta, Dhruv Parekh, Karen Piper Hanley, Manuela Plate, John Pearl, Krisnah Poinasamy, Jennifer K. Quint, Betty Raman, Matthew Richardson, Pilar Rivera-Ortega, Laura Saunders, Ruth Saunders, Malcolm G. Semple, Marco Sereno, Aarti Shikotra, A. John Simpson, Amisha Singapuri, David J. F. Smith, Mark Spears, Lisa G. Spencer, Stefan Stanel, David R. Thickett, A. A. Roger Thompson, Mathew Thorpe, Simon L. F. Walsh, Samantha Walker, Nicholas David Weatherley, Mark E. Weeks, Jim M. Wild, Dan G. Wootton, Chris E. Brightling, Ling-Pei Ho, Louise Wain, Gisli R. Jenkins

Summary: This study analyzed the data from the UK Interstitial Lung Disease Consortium (UKILD) post-COVID-19 study to estimate the prevalence of residual lung abnormalities in hospitalized COVID-19 patients. The results showed that approximately 11% of recovered COVID-19 patients had residual lung abnormalities, highlighting the need for long-term monitoring.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2023)

Article Biochemistry & Molecular Biology

Nitration of chemokine CXCL8 acts as a natural mechanism to limit acute inflammation

Sarah Thompson, Chong Yun Pang, Krishna Mohan Sepuru, Seppe Cambier, Thomas P. Hellyer, Jonathan Scott, A. John Simpson, Paul Proost, John A. Kirby, Krishna Rajarathnam, Neil S. Sheerin, Simi Ali

Summary: Chemokine CXCL8 plays a crucial role in human immune response by mediating neutrophil migration and activation at sites of infection and injury. This study demonstrates that peroxynitrite can nitrate CXCL8, leading to impaired neutrophil migration and activation. The nitrated chemokine showed reduced ability to induce neutrophil migration in vitro and failed to promote leukocyte recruitment in vivo due to impaired receptor signaling and binding to glycosaminoglycans. The presence of nitrated CXCL8 was detected in bronchoalveolar lavage samples from patients with pneumonia, providing the first direct evidence of chemokine nitration in human pathophysiology.

CELLULAR AND MOLECULAR LIFE SCIENCES (2023)

Article Respiratory System

Oropharyngeal swallowing physiology and safety in patients with Idiopathic Pulmonary Fibrosis: a consecutive descriptive case series

Amal Alamer, Rhys Jones, Michael Drinnan, A. John Simpson, Mike Griffin, Joanne M. Patterson, Abdullah Althuwaybi, Chris Ward, Ian A. Forrest

Summary: This study aimed to investigate oropharyngeal swallowing in patients with Idiopathic Pulmonary Fibrosis (IPF) and found that some patients showed swallowing difficulty, including aspiration into an unprotected airway.

BMC PULMONARY MEDICINE (2022)

Article Medicine, General & Internal

Role of immunosuppression in an antibiotic stewardship intervention and its association with clinical outcomes and antibiotic use: protocol for an observational study (RISC-sepsis)

Jonathan Scott, Loredana Trevi, Hannah McNeil, Tom Ewen, Phil Mawson, David McDonald, Andrew Filby, Ranjit Lall, Katie Booth, Gert Boschman, Vesna Melkebeek, Gavin Perkins, Ronan McMullan, Daniel F. McAuley, Iain J. McCullagh, Timothy Walsh, Anthony Rostron, Manu Shankar-Hari, Paul Dark, A. John Simpson, Andrew Conway Morris, Thomas P. Hellyer

Summary: This study aims to evaluate the impact of sepsis-associated immunosuppression on antibiotic stewardship. The effect of immunosuppression on trial outcomes will be determined through immunophenotyping analysis. The results of this study will contribute to guiding complex decisions and improving antibiotic management strategies.

BMJ OPEN (2022)

Article Chemistry, Medicinal

A Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Assay Identifies Nilotinib as an Inhibitor of Inflammation in Acute Myeloid Leukemia

Jose Luis Marin-Rubio, Rachel E. Peltier-Heap, Maria Emilia Duenas, Tiaan Heunis, Abeer Dannoura, Joseph Inns, Jonathan Scott, A. John Simpson, Helen J. Blair, Olaf Heidenreich, James M. Allan, Jessica E. Watt, Mathew P. Martin, Barbara Saxty, Matthias Trost

Summary: In this study, a label-free cellular phenotypic drug discovery assay was developed to identify anti-inflammatory drugs in acute myeloid leukemia cells. The results showed that nilotinib, but not imatinib, could block inflammatory responses. Further investigation revealed that nilotinib binds to p38α and inhibits the p38α-MK2/3 signaling axis, thereby suppressing pro-inflammatory cytokine expression, cell adhesion, and innate immunity markers in activated monocytes derived from AML.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Respiratory System

Mixed-methods feasibility cluster randomised controlled trial of a paramedic-administered breathlessness management intervention for acute-on-chronic breathlessness (BREATHE): study findings

Ann Hutchinson, Victoria Allgar, Judith Cohen, David C. Currow, Susan Griffin, Simon Hart, Kelly Hird, Andrew Hodge, Suzanne Mason, Matthew Northgraves, Joanne Reeve, Flavia Swan, Miriam J. Johnson

Summary: This study aimed to explore the effectiveness and cost-effectiveness of a paramedic-administered, non-pharmacological breathlessness intervention for people with acute-on-chronic breathlessness at ambulance call-out. However, due to the COVID-19 pandemic, patient recruitment to target was not feasible. Nevertheless, the study results provide valuable information on recruitment, consent, and data collection.

ERJ OPEN RESEARCH (2022)

Article Respiratory System

A feasibility cluster randomised controlled trial of a paramedic-administered breathlessness management intervention for acute-on-chronic breathlessness (BREATHE)

Matthew Northgraves, Judith Cohen, Victoria Allgar, David Currow, Simon Hart, Kelly Hird, Andrew Hodge, Miriam Johnson, Suzanne Mason, Flavia Swan, Ann Hutchinson

Summary: The BREATHE study aims to explore the feasibility and cost-effectiveness of a paramedic-administered non-pharmacological breathlessness intervention for patients with acute-onchronic breathlessness. By recruiting 60 participants and collecting data through a mixed-methods approach, the study will evaluate the effectiveness and acceptability of the intervention.

ERJ OPEN RESEARCH (2021)

暂无数据